Martino, E.A., Derudas, D., Rossi, E., Terlizzi, S., Reddiconto, G., Stefanoni, P., et al. (2024). Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials. HAEMATOLOGICA [10.3324/haematol.2024.286658].

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials

Botta, Cirino;
2024-11-28

28-nov-2024
Martino, E.A., Derudas, D., Rossi, E., Terlizzi, S., Reddiconto, G., Stefanoni, P., et al. (2024). Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials. HAEMATOLOGICA [10.3324/haematol.2024.286658].
File in questo prodotto:
File Dimensione Formato  
11854-Article Text-86467-1-10-20241128.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 1.73 MB
Formato Adobe PDF
1.73 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/665360
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact